High expression but no internal tandem duplication of FLT3 in normal hematopoietic cells
Citation
E. Ishii et al., High expression but no internal tandem duplication of FLT3 in normal hematopoietic cells, PED HEM ONC, 16(5), 1999, pp. 437-441
Categorie Soggetti
Pediatrics
Journal title
PEDIATRIC HEMATOLOGY AND ONCOLOGY
SICI code
0888-0018(199909/10)16:5<437:HEBNIT>2.0.ZU;2-0
Abstract
The FLT3 gene encodes a tyrosine kinase receptor that regulates proliferati
on and differentiation of hematopoietic cells. Recently, the internal dupli
cation of FLT3 has been observed in hematological malignancies, suggesting
the involvement of these mutations In leukemogenesis. The authors analyzed
the expression of FLT3 mRNA and the incidence of its internal tandem duplic
ation in normal hematopoietic and blood samples by reverse transcription-po
lymerase chain reaction (T-PCR). Mononuclear cells (MNCs) in cord blood and
bone marrow highly expressed FLT3 mRNA, whereas MCNs and polymorphonuclear
cells (PMNs) in peripheral blood showed low or undetectable levels of FLT3
. When the ratio of FLT3/beta-actin PCR products was calculated the level o
f FLT3 mRNA expression was significantly higher in cord blood MNCs (n = 42)
than that in peripheral MNCs (n = 14) or PMNs (n =10). Although several PC
R bands with different sizes were observed no internal tandem duplication o
f FLT3 was defected in these normal blood samples. These findings indicate
that the expression of FLT3 is lineage specific and consistently decreases
during hematopoietic differentiation. The internal duplication of FLT3 is r
estricted in hematological malignancies and may occur at a specific stage i
n leukemogenesis.